糖尿病黄斑浮腫薬の世界市場：インサイト・予測

• 英文タイトル：Global Diabetic Macular Edema Drug Market Insights, Forecast to 2025

• レポートコード：QYR9ST02854
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、112ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートでは、世界の糖尿病黄斑浮腫薬市場について調査・分析し、以下の構成でお届け致します。糖尿病黄斑浮腫薬の種類別には、硝子体内注射、硝子体内インプラントに、用途別には、抗VEGF、コルチコステロイド、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別糖尿病黄斑浮腫薬売上データ
・地域別糖尿病黄斑浮腫薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別糖尿病黄斑浮腫薬市場規模：硝子体内注射、硝子体内インプラント
・用途別糖尿病黄斑浮腫薬市場規模：抗VEGF、コルチコステロイド、その他
・主要メーカーの企業情報：Novartis、Bayer、Allergan、Hoffman-La Roche、Alimera、Valeant
・糖尿病黄斑浮腫薬の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...

Diabetic Macular Edema (DME) is a leading cause of blindness among the working age population in most developed countries. DME is one of the major complications of diabetes and DME patients utilise significantly higher healthcare resources than non-DME diabetic patients.Western Europe is expected to be the most lucrative market for diabetic macular edema, with market attractiveness index of 2.7.
The global Diabetic Macular Edema Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Diabetic Macular Edema Drug market based on company, product type, end user and key regions.

This report studies the global market size of Diabetic Macular Edema Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diabetic Macular Edema Drug in these regions.
This research report categorizes the global Diabetic Macular Edema Drug market by top players/brands, region, type and end user. This report also studies the global Diabetic Macular Edema Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Bayer
Allergan
Hoffman-La Roche
Alimera
Valeant

Market size by Product
Intravitreal Injections
Intravitreal Implants
Market size by End User
Anti-VEGF
Corticosteroids
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Diabetic Macular Edema Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Diabetic Macular Edema Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Diabetic Macular Edema Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Diabetic Macular Edema Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Diabetic Macular Edema Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diabetic Macular Edema Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Study Coverage
1.1 Diabetic Macular Edema Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Diabetic Macular Edema Drug Market Size Growth Rate by Product
1.4.2 Intravitreal Injections
1.4.3 Intravitreal Implants
1.5 Market by End User
1.5.1 Global Diabetic Macular Edema Drug Market Size Growth Rate by End User
1.5.2 Anti-VEGF
1.5.3 Corticosteroids
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Diabetic Macular Edema Drug Market Size
2.1.1 Global Diabetic Macular Edema Drug Revenue 2014-2025
2.1.2 Global Diabetic Macular Edema Drug Sales 2014-2025
2.2 Diabetic Macular Edema Drug Growth Rate by Regions
2.2.1 Global Diabetic Macular Edema Drug Sales by Regions
2.2.2 Global Diabetic Macular Edema Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Diabetic Macular Edema Drug Sales by Manufacturers
3.1.1 Diabetic Macular Edema Drug Sales by Manufacturers
3.1.2 Diabetic Macular Edema Drug Sales Market Share by Manufacturers
3.1.3 Global Diabetic Macular Edema Drug Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Macular Edema Drug Revenue by Manufacturers
3.2.1 Diabetic Macular Edema Drug Revenue by Manufacturers (2014-2019)
3.2.2 Diabetic Macular Edema Drug Revenue Share by Manufacturers (2014-2019)
3.3 Diabetic Macular Edema Drug Price by Manufacturers
3.4 Diabetic Macular Edema Drug Manufacturing Base Distribution, Product Types
3.4.1 Diabetic Macular Edema Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diabetic Macular Edema Drug Product Type
3.4.3 Date of International Manufacturers Enter into Diabetic Macular Edema Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Diabetic Macular Edema Drug Sales by Product
4.2 Global Diabetic Macular Edema Drug Revenue by Product
4.3 Diabetic Macular Edema Drug Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Diabetic Macular Edema Drug Breakdown Data by End User

6 North America
6.1 North America Diabetic Macular Edema Drug by Countries
6.1.1 North America Diabetic Macular Edema Drug Sales by Countries
6.1.2 North America Diabetic Macular Edema Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Diabetic Macular Edema Drug by Product
6.3 North America Diabetic Macular Edema Drug by End User

7 Europe
7.1 Europe Diabetic Macular Edema Drug by Countries
7.1.1 Europe Diabetic Macular Edema Drug Sales by Countries
7.1.2 Europe Diabetic Macular Edema Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Diabetic Macular Edema Drug by Product
7.3 Europe Diabetic Macular Edema Drug by End User

8 Asia Pacific
8.1 Asia Pacific Diabetic Macular Edema Drug by Countries
8.1.1 Asia Pacific Diabetic Macular Edema Drug Sales by Countries
8.1.2 Asia Pacific Diabetic Macular Edema Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Diabetic Macular Edema Drug by Product
8.3 Asia Pacific Diabetic Macular Edema Drug by End User

9 Central & South America
9.1 Central & South America Diabetic Macular Edema Drug by Countries
9.1.1 Central & South America Diabetic Macular Edema Drug Sales by Countries
9.1.2 Central & South America Diabetic Macular Edema Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Diabetic Macular Edema Drug by Product
9.3 Central & South America Diabetic Macular Edema Drug by End User

10 Middle East and Africa
10.1 Middle East and Africa Diabetic Macular Edema Drug by Countries
10.1.1 Middle East and Africa Diabetic Macular Edema Drug Sales by Countries
10.1.2 Middle East and Africa Diabetic Macular Edema Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Diabetic Macular Edema Drug by Product
10.3 Middle East and Africa Diabetic Macular Edema Drug by End User

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis Diabetic Macular Edema Drug Products Offered
11.1.5 Novartis Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Company Business Overview
11.2.3 Bayer Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bayer Diabetic Macular Edema Drug Products Offered
11.2.5 Bayer Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Company Business Overview
11.3.3 Allergan Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Allergan Diabetic Macular Edema Drug Products Offered
11.3.5 Allergan Recent Development
11.4 Hoffman-La Roche
11.4.1 Hoffman-La Roche Company Details
11.4.2 Company Business Overview
11.4.3 Hoffman-La Roche Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Hoffman-La Roche Diabetic Macular Edema Drug Products Offered
11.4.5 Hoffman-La Roche Recent Development
11.5 Alimera
11.5.1 Alimera Company Details
11.5.2 Company Business Overview
11.5.3 Alimera Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Alimera Diabetic Macular Edema Drug Products Offered
11.5.5 Alimera Recent Development
11.6 Valeant
11.6.1 Valeant Company Details
11.6.2 Company Business Overview
11.6.3 Valeant Diabetic Macular Edema Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Valeant Diabetic Macular Edema Drug Products Offered
11.6.5 Valeant Recent Development

12 Future Forecast
12.1 Diabetic Macular Edema Drug Market Forecast by Regions
12.1.1 Global Diabetic Macular Edema Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Diabetic Macular Edema Drug Revenue Forecast by Regions 2019-2025
12.2 Diabetic Macular Edema Drug Market Forecast by Product
12.2.1 Global Diabetic Macular Edema Drug Sales Forecast by Product 2019-2025
12.2.2 Global Diabetic Macular Edema Drug Revenue Forecast by Product 2019-2025
12.3 Diabetic Macular Edema Drug Market Forecast by End User
12.4 North America Diabetic Macular Edema Drug Forecast
12.5 Europe Diabetic Macular Edema Drug Forecast
12.6 Asia Pacific Diabetic Macular Edema Drug Forecast
12.7 Central & South America Diabetic Macular Edema Drug Forecast
12.8 Middle East and Africa Diabetic Macular Edema Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Diabetic Macular Edema Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Diabetic Macular Edema Drug Product Picture
Table Diabetic Macular Edema Drug Market Segments
Table Key Manufacturers Diabetic Macular Edema Drug Covered
Table Global Diabetic Macular Edema Drug Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)
Figure Global Diabetic Macular Edema Drug Sales Market Share by Product 2014-2025
Figure Intravitreal Injections Product Picture
Table Major Manufacturers of Intravitreal Injections
Figure Intravitreal Implants Product Picture
Table Major Manufacturers of Intravitreal Implants
Table Global Diabetic Macular Edema Drug Market Size Growth Rate by End User 2019-2025 (K Pcs)
Figure Anti-VEGF
Figure Corticosteroids
Figure Others
Figure Diabetic Macular Edema Drug Report Years Considered
Figure Global Diabetic Macular Edema Drug Market Size 2014-2025 (Million US$)
Figure Global Diabetic Macular Edema Drug Sales 2014-2025 (K Pcs)
Table Global Diabetic Macular Edema Drug Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Diabetic Macular Edema Drug Sales by Regions 2014-2019 (K Pcs)
Table Global Diabetic Macular Edema Drug Sales Market Share by Regions 2014-2019
Figure Global Diabetic Macular Edema Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Diabetic Macular Edema Drug Sales Market Share by Regions
Table Global Diabetic Macular Edema Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Diabetic Macular Edema Drug Revenue Market Share by Regions 2014-2019
Figure Global Diabetic Macular Edema Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Diabetic Macular Edema Drug Revenue Market Share by Regions
Table Global Diabetic Macular Edema Drug Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Diabetic Macular Edema Drug Sales Share by Manufacturers (2014-2019)
Figure Global Diabetic Macular Edema Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Diabetic Macular Edema Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Diabetic Macular Edema Drug Revenue Share by Manufacturers (2014-2019)
Figure Diabetic Macular Edema Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Diabetic Macular Edema Drug Price (2014-2019) (USD/Pcs)
Table Diabetic Macular Edema Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Diabetic Macular Edema Drug Product Type
Table Date of International Manufacturers Enter into Diabetic Macular Edema Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Diabetic Macular Edema Drug Sales by Product (2014-2019) (K Pcs)
Table Global Diabetic Macular Edema Drug Sales Share by Product (2014-2019)
Figure Global Diabetic Macular Edema Drug Sales Market Share by Product (2014-2019)
Figure Global Diabetic Macular Edema Drug Sales Market Share by Product in 2018
Table Global Diabetic Macular Edema Drug Revenue by Product (2014-2019) (Million US$)
Table Global Diabetic Macular Edema Drug Revenue Share by Product (2014-2019)
Figure Global Diabetic Macular Edema Drug Revenue Market Share by Product (2014-2019)
Figure Global Diabetic Macular Edema Drug Revenue Market Share by Product in 2018
Table Diabetic Macular Edema Drug Price by Product 2014-2019 (USD/Pcs)
Table Global Diabetic Macular Edema Drug Sales by End User (2014-2019) (K Pcs)
Table Global Diabetic Macular Edema Drug Sales Share by End User (2014-2019)
Figure Global Sales Diabetic Macular Edema Drug Market Share by End User (2014-2019)
Figure Global Sales Diabetic Macular Edema Drug Market Share by End User in 2018
Figure North America Diabetic Macular Edema Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Diabetic Macular Edema Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Diabetic Macular Edema Drug Sales by Countries (2014-2019) (K Pcs)
Table North America Diabetic Macular Edema Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Diabetic Macular Edema Drug Sales Market Share by Countries
Table North America Diabetic Macular Edema Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Diabetic Macular Edema Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Diabetic Macular Edema Drug Revenue Market Share by Countries
Figure United States Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Diabetic Macular Edema Drug Sales by Product (2014-2019) (K Pcs)
Table North America Diabetic Macular Edema Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Diabetic Macular Edema Drug Market Share by Product
Table North America Diabetic Macular Edema Drug Sales by End User (2014-2019) (K Pcs)
Table North America Diabetic Macular Edema Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Diabetic Macular Edema Drug Market Share by End User
Figure Europe Diabetic Macular Edema Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Diabetic Macular Edema Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Diabetic Macular Edema Drug Sales by Countries (2014-2019) (K Pcs)
Table Europe Diabetic Macular Edema Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Diabetic Macular Edema Drug Sales Market Share by Countries
Table Europe Diabetic Macular Edema Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Diabetic Macular Edema Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Diabetic Macular Edema Drug Revenue Market Share by Countries
Figure Germany Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure France Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Diabetic Macular Edema Drug Sales by Product (2014-2019) (K Pcs)
Table Europe Diabetic Macular Edema Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Diabetic Macular Edema Drug Market Share by Product
Table Europe Diabetic Macular Edema Drug Sales by End User (2014-2019) (K Pcs)
Table Europe Diabetic Macular Edema Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Diabetic Macular Edema Drug Market Share by End User
Figure Asia Pacific Diabetic Macular Edema Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Diabetic Macular Edema Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Diabetic Macular Edema Drug Sales by Countries (2014-2019) (K Pcs)
Table Asia Pacific Diabetic Macular Edema Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Diabetic Macular Edema Drug Sales Market Share by Countries
Table Asia Pacific Diabetic Macular Edema Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Diabetic Macular Edema Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Diabetic Macular Edema Drug Revenue Market Share by Countries
Figure China Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure China Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure India Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Diabetic Macular Edema Drug Sales by Product (2014-2019) (K Pcs)
Table Asia Pacific Diabetic Macular Edema Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Diabetic Macular Edema Drug Market Share by Product
Table Asia Pacific Diabetic Macular Edema Drug Sales by End User (2014-2019) (K Pcs)
Table Asia Pacific Diabetic Macular Edema Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Diabetic Macular Edema Drug Market Share by End User
Figure Central & South America Diabetic Macular Edema Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Diabetic Macular Edema Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Diabetic Macular Edema Drug Sales by Countries (2014-2019) (K Pcs)
Table Central & South America Diabetic Macular Edema Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Diabetic Macular Edema Drug Sales Market Share by Countries
Table Central & South America Diabetic Macular Edema Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Diabetic Macular Edema Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Diabetic Macular Edema Drug Revenue Market Share by Countries
Figure Brazil Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Diabetic Macular Edema Drug Sales by Product (2014-2019) (K Pcs)
Table Central & South America Diabetic Macular Edema Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Diabetic Macular Edema Drug Market Share by Product
Table Central & South America Diabetic Macular Edema Drug Sales by End User (2014-2019) (K Pcs)
Table Central & South America Diabetic Macular Edema Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Diabetic Macular Edema Drug Market Share by End User
Figure Middle East and Africa Diabetic Macular Edema Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Diabetic Macular Edema Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Diabetic Macular Edema Drug Sales by Countries (2014-2019) (K Pcs)
Table Middle East and Africa Diabetic Macular Edema Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Diabetic Macular Edema Drug Sales Market Share by Countries
Table Middle East and Africa Diabetic Macular Edema Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Diabetic Macular Edema Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Diabetic Macular Edema Drug Revenue Market Share by Countries
Figure GCC Countries Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Diabetic Macular Edema Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Diabetic Macular Edema Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Diabetic Macular Edema Drug Sales by Product (2014-2019) (K Pcs)
Table Middle East and Africa Diabetic Macular Edema Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Diabetic Macular Edema Drug Market Share by Product
Table Middle East and Africa Diabetic Macular Edema Drug Sales by End User (2014-2019) (K Pcs)
Table Middle East and Africa Diabetic Macular Edema Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Diabetic Macular Edema Drug Market Share by End User
Table Novartis Company Details
Table Novartis Diabetic Macular Edema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis Recent Development

Table Bayer Company Details
Table Bayer Diabetic Macular Edema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer Recent Development

Table Allergan Company Details
Table Allergan Diabetic Macular Edema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Allergan Recent Development

Table Hoffman-La Roche Company Details
Table Hoffman-La Roche Diabetic Macular Edema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hoffman-La Roche Recent Development

Table Alimera Company Details
Table Alimera Diabetic Macular Edema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alimera Recent Development

Table Valeant Company Details
Table Valeant Diabetic Macular Edema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Valeant Recent Development

Table Global Diabetic Macular Edema Drug Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Diabetic Macular Edema Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Diabetic Macular Edema Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Diabetic Macular Edema Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Diabetic Macular Edema Drug Sales Forecast by Product 2019-2025 (K Pcs)
Table Global Diabetic Macular Edema Drug Sales Market Share Forecast by Product 2019-2025
Table Global Diabetic Macular Edema Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Diabetic Macular Edema Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Diabetic Macular Edema Drug Sales Forecast by End User 2019-2025 (K Pcs)
Table Global Diabetic Macular Edema Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Diabetic Macular Edema Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Diabetic Macular Edema Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Diabetic Macular Edema Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Diabetic Macular Edema Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Diabetic Macular Edema Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Diabetic Macular Edema Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Diabetic Macular Edema Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Diabetic Macular Edema Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Diabetic Macular Edema Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Diabetic Macular Edema Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Diabetic Macular Edema Drug Value Chain
Table Diabetic Macular Edema Drug Customers List
Table Diabetic Macular Edema Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

非感染性黄斑浮腫治療の世界市場：市場規模・現状・予測

Global Non-infectious Macular Edema Treatment Market Size, Status and Forecast 2019-2025
QYR9ST09571 2019年9月5日 96Pages
※当調査レポートでは、非感染性黄斑浮腫治療の世界市場について調査・分析し、非感染性黄斑浮腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗VEGF療法、コルチコステロイド、免疫抑制剤、生物学的...

黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場：市場規模・現状・予測

Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, Status and Forecast 2019-2025
QYR9ST04929 2019年9月2日 91Pages
※当調査レポートでは、黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場について調査・分析し、黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（...

世界の経口抗糖尿病薬市場：専門的調査

Global Oral Anti-Diabetic Drug Market Professional Survey Report 2019
QYR9ST12353 2019年9月10日 116Pages
※本調査レポートは、経口抗糖尿病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グリメピリド、グリクラジド、グリブリド、その他に、用途別には、病院、研究機関...

糖尿病食品の世界市場：インサイト・予測

Global Diabetic Food Market Insights, Forecast to 2025
QYR9ST02400 2019年9月2日 119Pages
※本調査レポートでは、世界の糖尿病食品市場について調査・分析し、以下の構成でお届け致します。糖尿病食品の種類別には、糖尿病飲料、糖尿病乳製品に、用途別には、店舗、オンライン小売に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメ...

糖尿病性足潰瘍の治療の世界市場：インサイト・予測

Global Diabetic Foot Ulcers Treatment Market Insights, Forecast to 2025
QYR9ST00122 2019年9月2日 114Pages
※本調査レポートでは、世界の糖尿病性足潰瘍の治療市場について調査・分析し、以下の構成でお届け致します。糖尿病性足潰瘍の治療の種類別には、創傷ケアドレッシング（フォームドレッシング、ハイドロコロイドドレッシング、ハイドロゲルドレッシング、アルギン酸ドレッシング、およびその他のドレッシング）、生物製剤（...

糖尿病性ソックスの世界市場：インサイト・予測

Global Diabetic Socks Market Insights, Forecast to 2025
QYR9ST00884 2019年9月2日 117Pages
※本調査レポートでは、世界の糖尿病性ソックス市場について調査・分析し、以下の構成でお届け致します。糖尿病性ソックスの種類別には、レギュラーソックス、スマートソックスに、用途別には、小売店、オンラインストア、現代貿易、薬局、診療所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国...

加齢黄斑変性（AMD）の世界市場：市場規模・現状・予測

Global Age Related Macular Degeneration (AMD) Market Size, Status and Forecast 2019-2025
QYR9ST04093 2019年9月2日 90Pages
※当調査レポートでは、加齢黄斑変性（AMD）の世界市場について調査・分析し、加齢黄斑変性（AMD）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ウエットAMD、ドライAMD）、用途別（男性、女性）...

加齢黄斑変性症遺伝子治療の世界市場：市場規模・現状・予測

Global Gene Therapy for Age-related Macular Degeneration Market Size, Status and Forecast 2019-2025
QYR9ST03893 2019年9月2日 93Pages
※当調査レポートでは、加齢黄斑変性症遺伝子治療の世界市場について調査・分析し、加齢黄斑変性症遺伝子治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（網膜下、硝子体内、不特定）、用途別（単独療法、併...

レブリミド薬の世界市場：インサイト・予測

Global Revlimid Drug Market Insights, Forecast to 2025
QYR9ST02645 2019年9月2日 116Pages
※本調査レポートでは、世界のレブリミド薬市場について調査・分析し、以下の構成でお届け致します。レブリミド薬の種類別には、10mg、25mg、その他に、用途別には、病院、薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセ...

アフィニトール薬の世界市場：インサイト・予測

Global Afinitor Drug Market Insights, Forecast to 2025
QYR9ST00769 2019年9月2日 114Pages
※本調査レポートでは、世界のアフィニトール薬市場について調査・分析し、以下の構成でお届け致します。アフィニトール薬の種類別には、2.5mg、5mg、7mg、10mgに、用途別には、病院、ドラッグストア、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中...

非感染性黄斑浮腫治療の世界市場：市場規模・現状・予測 Non-infectious Macular Edema Treatment refers to the treatment of Non-infectious Macular Edema by drugs or therapies such as anti-VEGF therapy, corticosteroids, immunosuppressive agents, and biological agents. The macula is a region of the center of the retina. Macular edema is the accumulation of f…
黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場：市場規模・現状・予測 Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…
世界の経口抗糖尿病薬市場：専門的調査 Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are of…
加齢黄斑変性症遺伝子治療の世界市場：市場規模・現状・予測 Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
加齢黄斑変性（AMD）の世界市場：市場規模・現状・予測 Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.In 2018, the global Age Related Macular Degeneration (AMD) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAG…